ZA893441B - Pharmaceutical solutions of triamterene - Google Patents

Pharmaceutical solutions of triamterene

Info

Publication number
ZA893441B
ZA893441B ZA893441A ZA893441A ZA893441B ZA 893441 B ZA893441 B ZA 893441B ZA 893441 A ZA893441 A ZA 893441A ZA 893441 A ZA893441 A ZA 893441A ZA 893441 B ZA893441 B ZA 893441B
Authority
ZA
South Africa
Prior art keywords
triamterene
pharmaceutical solutions
pharmaceutical
solutions
Prior art date
Application number
ZA893441A
Other languages
English (en)
Inventor
Kap Shik Ahn
Shik Ahn Kap
Original Assignee
Multilan Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multilan Ag filed Critical Multilan Ag
Publication of ZA893441B publication Critical patent/ZA893441B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA893441A 1988-05-13 1989-05-09 Pharmaceutical solutions of triamterene ZA893441B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/193,890 US4981852A (en) 1988-05-13 1988-05-13 Chemical compounds triamterene and hydrochlorothiazide

Publications (1)

Publication Number Publication Date
ZA893441B true ZA893441B (en) 1990-10-31

Family

ID=22715436

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA893441A ZA893441B (en) 1988-05-13 1989-05-09 Pharmaceutical solutions of triamterene

Country Status (9)

Country Link
US (1) US4981852A (xx)
EP (1) EP0341774A1 (xx)
JP (1) JPH0215030A (xx)
AU (1) AU617801B2 (xx)
DK (1) DK229789A (xx)
FI (1) FI892288A (xx)
NZ (1) NZ229089A (xx)
PT (1) PT90554A (xx)
ZA (1) ZA893441B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177090A (en) * 1987-07-07 1993-01-05 Bayer Aktiengesellschaft Microbicidal agents
JP2995595B2 (ja) * 1990-12-19 1999-12-27 武田薬品工業株式会社 ドリンク剤
US6991812B2 (en) * 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
US11878022B2 (en) 2020-12-10 2024-01-23 Novitium Pharma LLC Hydrochlorothiazide compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081230A (en) * 1960-09-08 1963-03-12 Smith Kline French Lab Diuretic and antihypertensive triaminoarylpteridines
US3901971A (en) * 1973-09-10 1975-08-26 Union Corp Sustained release of hydrochlorothiazide
US4255413A (en) * 1979-10-01 1981-03-10 Smithkline Corporation Gelatin capsule dosage unit containing triamterene
US4285947A (en) * 1980-01-18 1981-08-25 Interx Research Corporation Aldehyde adducts of triamterene
AU7344681A (en) * 1980-08-01 1982-02-04 Smith & Nephew Associated Companies Plc Composition for topical application to the eye containing triamterene
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
US4526777A (en) * 1983-01-06 1985-07-02 Mylan Pharmaceuticals Inc. Pharmaceutical combination composition and associated method
US4547498A (en) * 1983-01-06 1985-10-15 Mylan Pharmaceuticals Inc. Pharmaceutical combination composition and associated method
CH668553A5 (de) * 1987-02-02 1989-01-13 Mepha Ag Arzneimittel mit verzoegerter wirkstofffreisetzung.

Also Published As

Publication number Publication date
AU3474289A (en) 1989-11-16
FI892288A (fi) 1989-11-14
DK229789A (da) 1989-11-14
PT90554A (pt) 1989-11-30
JPH0215030A (ja) 1990-01-18
EP0341774A1 (en) 1989-11-15
NZ229089A (en) 1991-09-25
US4981852A (en) 1991-01-01
FI892288A0 (fi) 1989-05-11
DK229789D0 (da) 1989-05-10
AU617801B2 (en) 1991-12-05

Similar Documents

Publication Publication Date Title
GB8819477D0 (en) Medicaments
CS8700282A2 (en) Nicorandil-containing stable pharmaceutical
GB8924052D0 (en) Pharmaceutical solution
GB8816187D0 (en) Medicaments
GB8805269D0 (en) Medicaments
GB8805268D0 (en) Medicaments
GB8814726D0 (en) Medicaments
ZA893441B (en) Pharmaceutical solutions of triamterene
GB8820651D0 (en) Medicaments
NZ230921A (en) 3-phenyloxymethyl-cephalosporin derivatives and medicaments
GB8820650D0 (en) Medicaments
ZA9015B (en) Pharmaceutical formulation
GB8814725D0 (en) Medicaments
GB8820653D0 (en) Medicaments
IE891565L (en) Solutions of triamterene
NZ221491A (en) Penicillin derivatives and pharmaceutical compositions
GB8821819D0 (en) Medicine
GB8823850D0 (en) Pharmaceutical formulation
GB8806818D0 (en) Pharmaceutical formulation
GB8820270D0 (en) Pharmaceutical formulation
GB8826542D0 (en) Pharmaceutical formulation
GB8620463D0 (en) Pharmaceutical
GB8701281D0 (en) Pharmaceutical solution
BG40991A1 (en) Medicinal form containing trans- 1- benzhydryl- 4- cynamylpiperazine or its derivatives
BG43026A1 (en) Lyposomic pharmaceutical form